Literature DB >> 27844096

[Chronic kidney disease : What is currently available for treatment?]

S Fleig1, M Patecki2, R Schmitt2.   

Abstract

Chronic kidney disease is common in the general population with an estimated prevalence of roughly 2 million in Germany. Typically, chronic kidney disease is progressive and in the terminal stage the patients require dialysis or kidney transplantation. In many cases the disease remains silent for a long time but early stages are already associated with increasing morbidity and mortality. Therefore early detection is very important. In recent years several new concepts have been introduced that might help to slow the progression of chronic kidney disease or improve the accompanying risks. Here, we want to provide a nephrologist's perspective on the current guidelines for the treatment and prevention of chronic kidney disease. We summarize which diagnostic approaches are useful for general practitioners and we take a pragmatic look at the existing opportunities for combating renal functional decline. We also shed light on established measures to minimize the risk of comorbidities.

Entities:  

Keywords:  Antihypertensive agents; Diabetes mellitus; Disease progression; Glomerular filtration rate; Vaccination, influenza

Mesh:

Substances:

Year:  2016        PMID: 27844096     DOI: 10.1007/s00108-016-0150-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury.

Authors:  Paul M Palevsky; Kathleen D Liu; Patrick D Brophy; Lakhmir S Chawla; Chirag R Parikh; Charuhas V Thakar; Ashita J Tolwani; Sushrut S Waikar; Steven D Weisbord
Journal:  Am J Kidney Dis       Date:  2013-03-15       Impact factor: 8.860

Review 3.  Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.

Authors:  Joseph A Vassalotti; Robert Centor; Barbara J Turner; Raquel C Greer; Michael Choi; Thomas D Sequist
Journal:  Am J Med       Date:  2015-09-25       Impact factor: 4.965

Review 4.  The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease.

Authors:  Giuseppe Remuzzi; Norberto Perico; Manuel Macia; Piero Ruggenenti
Journal:  Kidney Int Suppl       Date:  2005-12       Impact factor: 10.545

Review 5.  Effects of dietary interventions on incidence and progression of CKD.

Authors:  Nishank Jain; Robert F Reilly
Journal:  Nat Rev Nephrol       Date:  2014-10-21       Impact factor: 28.314

6.  Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.

Authors:  Kyle E Rodenbach; Michael F Schneider; Susan L Furth; Marva M Moxey-Mims; Mark M Mitsnefes; Donald J Weaver; Bradley A Warady; George J Schwartz
Journal:  Am J Kidney Dis       Date:  2015-07-21       Impact factor: 8.860

7.  Bicarbonate supplementation slows progression of CKD and improves nutritional status.

Authors:  Ione de Brito-Ashurst; Mira Varagunam; Martin J Raftery; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

8.  KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.

Authors: 
Journal:  Am J Kidney Dis       Date:  2012-11       Impact factor: 8.860

9.  Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Dipankar Sircar; Soumya Chatterjee; Rajesh Waikhom; Vishal Golay; Arpita Raychaudhury; Suparna Chatterjee; Rajendra Pandey
Journal:  Am J Kidney Dis       Date:  2015-07-30       Impact factor: 8.860

10.  Ketoanalogue-Supplemented Vegetarian Very Low-Protein Diet and CKD Progression.

Authors:  Liliana Garneata; Alexandra Stancu; Diana Dragomir; Gabriel Stefan; Gabriel Mircescu
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.